NCC MERP category* | No pADEs | pADEs | ||||||
B (%) | C (%) | D (%) | E (%) | F (%) | G (%) | H (%) | I (%) | |
Prescribing | ||||||||
Administrative (n = 2522) | 2516 (99.8) | 6 (0.2) | – | – | – | – | – | – |
Dosing (n = 1658) | 1396 (84.2) | 220 (13.3) | 8 (0.5) | 30 (1.8) | 1 (0.1) | – | 2 (0.1) | 1 (0.1) |
Therapeutic (n = 340) | 25 (7.4) | 255 (75) | 4 (1.2) | 50 (14.7) | 6 (1.8) | – | – | – |
Transcribing (n = 1205) | 1020 (84.6) | 167 (13.9) | 5 (0.4) | 12 (1.0) | 1 (0.1) | – | – | – |
Total (n = 5725) | 4957 (86.6) | 648 (11.3) | 17 (0.3) | 92 (1.6) | 8 (0.1) | – | 2 (0.0) | 1 (0.0) |
*National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) Index for categorising medication errors: B, an error occurred but the error did not reach the patient; C, an error occurred that reached the patient but did not cause patient harm; D, an error occurred that reached the patient and required monitoring to confirm that it resulted in no harm to the patient and/or required intervention to preclude harm; E, an error occurred that may have contributed to or resulted in temporary harm to the patient and required intervention; F, an error occurred that may have contributed to or resulted in temporary harm to the patient and required initial or prolonged hospitalisation; G, an error occurred that may have contributed to or resulted in permanent patient harm; H, an error occurred that required intervention necessary to sustain life; I, an error occurred that may have contributed to or resulted in the patient’s death.
pADE, preventable adverse drug event.